Humana AB (publ) (HUM) - Net Assets

Latest as of December 2025: Skr3.25 Billion SEK ≈ $350.29 Million USD

Based on the latest financial reports, Humana AB (publ) (HUM) has net assets worth Skr3.25 Billion SEK (≈ $350.29 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr9.39 Billion ≈ $1.01 Billion USD) and total liabilities (Skr6.14 Billion ≈ $660.65 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check HUM asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Skr3.25 Billion
% of Total Assets	34.65%
Annual Growth Rate	13.49%
5-Year Change	27.5%
10-Year Change	88.59%
Growth Volatility	15.13

Humana AB (publ) - Net Assets Trend (2012–2025)

This chart illustrates how Humana AB (publ)'s net assets have evolved over time, based on quarterly financial data. Also explore Humana AB (publ) (HUM) total assets for the complete picture of this company's asset base.

Annual Net Assets for Humana AB (publ) (2012–2025)

The table below shows the annual net assets of Humana AB (publ) from 2012 to 2025. For live valuation and market cap data, see how much is Humana AB (publ) worth.

Year	Net Assets	Change
2025-12-31	Skr3.25 Billion ≈ $350.29 Million	-1.12%
2024-12-31	Skr3.29 Billion ≈ $354.27 Million	+12.55%
2023-12-31	Skr2.92 Billion ≈ $314.78 Million	+6.79%
2022-12-31	Skr2.74 Billion ≈ $294.76 Million	+7.29%
2021-12-31	Skr2.55 Billion ≈ $274.74 Million	+8.45%
2020-12-31	Skr2.35 Billion ≈ $253.33 Million	+2.08%
2019-12-31	Skr2.31 Billion ≈ $248.16 Million	+7.41%
2018-12-31	Skr2.15 Billion ≈ $231.05 Million	+13.54%
2017-12-31	Skr1.89 Billion ≈ $203.50 Million	+9.56%
2016-12-31	Skr1.73 Billion ≈ $185.75 Million	+57.91%
2015-12-31	Skr1.09 Billion ≈ $117.62 Million	+10.85%
2014-12-31	Skr986.00 Million ≈ $106.11 Million	+15.59%
2013-12-31	Skr853.00 Million ≈ $91.80 Million	+35.72%
2012-12-31	Skr628.48 Million ≈ $67.63 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Humana AB (publ)'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 210.6% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Retained Earnings	Skr1.95 Billion	62.53%
Common Stock	Skr1.00 Million	0.03%
Other Comprehensive Income	Skr-62.00 Million	-1.99%
Other Components	Skr1.23 Billion	39.43%
Total Equity	Skr3.12 Billion	100.00%

Humana AB (publ) Competitors by Market Cap

The table below lists competitors of Humana AB (publ) ranked by their market capitalization.

Company	Market Cap
Te Chang Construction Co Ltd TWO:5511	$252.32 Million
AK Sigorta AS IS:AKGRT	$252.37 Million
VNV Global AB ST:VNV	$252.46 Million
Saha-Union Public Company Limited BK:SUC	$252.47 Million
Aldel Financial II Inc. Class A Ordinary Shares NASDAQ:ALDF	$252.25 Million
Tiansheng Pharmaceutical Group Co Ltd SHE:002872	$252.21 Million
Bioteque TWO:4107	$252.17 Million
SiS Distribution (Thailand) Public Company Limited BK:SIS	$252.15 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Humana AB (publ)'s equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 3,162,000,000 to 3,117,000,000, a change of -45,000,000 (-1.4%).
Net income of 237,000,000 contributed positively to equity growth.
Dividend payments of 50,000,000 reduced retained earnings.
Share repurchases of 153,000,000 reduced equity.
Other comprehensive income decreased equity by 84,000,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	Skr237.00 Million	+7.6%
Dividends Paid	Skr50.00 Million	-1.6%
Share Repurchases	Skr153.00 Million	-4.91%
Other Comprehensive Income	Skr-84.00 Million	-2.69%
Other Changes	Skr5.00 Million	+0.16%
Total Change	Skr-	-1.42%

Book Value vs Market Value Analysis

This analysis compares Humana AB (publ)'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 0.81x
The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
The price-to-book ratio has decreased from 3.47x to 0.81x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2012-12-31	Skr13.97	Skr48.50	x
2013-12-31	Skr15.90	Skr48.50	x
2014-12-31	Skr18.38	Skr48.50	x
2015-12-31	Skr20.38	Skr48.50	x
2016-12-31	Skr33.50	Skr48.50	x
2017-12-31	Skr35.59	Skr48.50	x
2018-12-31	Skr49.37	Skr48.50	x
2019-12-31	Skr42.98	Skr48.50	x
2020-12-31	Skr44.42	Skr48.50	x
2021-12-31	Skr52.42	Skr48.50	x
2022-12-31	Skr57.11	Skr48.50	x
2023-12-31	Skr60.34	Skr48.50	x
2024-12-31	Skr63.03	Skr48.50	x
2025-12-31	Skr60.14	Skr48.50	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Humana AB (publ) utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 7.60%
The company has moderate efficiency in generating returns from equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 2.37%
• Asset Turnover: 1.07x
• Equity Multiplier: 3.01x
Recent ROE (7.60%) is below the historical average (9.31%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2012	7.00%	1.47%	1.72x	2.76x	Skr-18.87 Million
2013	20.98%	5.13%	1.59x	2.57x	Skr93.70 Million
2014	11.66%	2.27%	1.38x	3.71x	Skr16.40 Million
2015	4.21%	0.82%	1.46x	3.51x	Skr-63.30 Million
2016	8.57%	2.33%	1.28x	2.87x	Skr-24.60 Million
2017	10.26%	2.97%	1.29x	2.68x	Skr4.90 Million
2018	11.50%	3.65%	1.29x	2.45x	Skr32.00 Million
2019	8.23%	2.52%	0.90x	3.60x	Skr-40.40 Million
2020	11.13%	3.37%	0.97x	3.42x	Skr26.60 Million
2021	10.81%	3.37%	0.91x	3.53x	Skr20.70 Million
2022	7.67%	2.28%	0.94x	3.58x	Skr-63.90 Million
2023	6.10%	1.82%	0.96x	3.48x	Skr-112.60 Million
2024	4.55%	1.40%	0.97x	3.36x	Skr-172.20 Million
2025	7.60%	2.37%	1.07x	3.01x	Skr-74.70 Million

Industry Comparison

This section compares Humana AB (publ)'s net assets metrics with peer companies in the Medical Care Facilities industry.

Industry Context

Industry: Medical Care Facilities
Average net assets among peers: $2,497,195,250
Average return on equity (ROE) among peers: -7.18%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Humana AB (publ) (HUM)	Skr3.25 Billion	7.00%	1.89x	$252.31 Million
Ambea AB (AMBEA)	$4.99 Billion	12.43%	2.71x	$1.24 Billion
Attendo AB (publ) (ATT)	$4.96 Billion	1.13%	3.25x	$1.66 Billion
Medicover AB (publ) (MCOV-B)	$23.55 Million	5.95%	0.72x	$1.66 Billion
ProstaLund AB (PLUN)	$22.23 Million	-48.25%	0.19x	$716.78K

About Humana AB (publ)

ST:HUM Sweden Medical Care Facilities

Market Cap

$252.31 Million

Skr2.34 Billion SEK

Market Cap Rank

#15658 Global

#252 in Sweden

Share Price

Skr48.50

Change (1 day)

+0.31%

52-Week Range

Skr34.00 - Skr52.20

All Time High

Skr83.90